Trial Selection Rising

ALK fusion

solid tumor basket · Combination Therapy

ALK fusion is flagged as trial selection rising because public trials show inclusion required evidence in 30 contexts. FDA CDx context should be reviewed manually.

Role evidence

Usage summary

Strongest role: Inclusion Required

Inclusion-required count: 26

Treatment-assignment count: 0

Stratification count: 1

Threshold snippets

Fragmentation view

Threshold count: 5

Common snippets: BRAF V600E | MSI-H | dMMR

Threshold label: Moderate

FDA CDx context

Mapping summary

CDx label: Fda Cdx Context Manual Review Required

CDx maturity score: 2/5

Confidence: High

Patent-density signal

Diagnostic appendix

Signal count: 0

Recent signals: 0

Density label: Low

Source links

Evidence paths

https://clinicaltrials.gov/study/NCT02228681 | https://clinicaltrials.gov/study/NCT07334301 | https://clinicaltrials.gov/study/NCT03513952 | https://clinicaltrials.gov/study/NCT01208454 | https://clinicaltrials.gov/study/NCT01141244 | https://clinicaltrials.gov/study/NCT02554812 | https://clinicaltrials.gov/study/NCT02975882 | https://clinicaltrials.gov/study/NCT01289522 | https://clinicaltrials.gov/study/NCT00047047 | https://clinicaltrials.gov/study/NCT01325441 | https://clinicaltrials.gov/study/NCT04988074 | https://clinicaltrials.gov/study/NCT00137436 | https://clinicaltrials.gov/study/NCT01130519 | https://clinicaltrials.gov/study/NCT04800822 | https://clinicaltrials.gov/study/NCT02929693 | https://clinicaltrials.gov/study/NCT02689336 | https://clinicaltrials.gov/study/NCT01154140 | https://clinicaltrials.gov/study/NCT07608224 | https://clinicaltrials.gov/study/NCT05618925 | https://clinicaltrials.gov/study/NCT04803994 | https://clinicaltrials.gov/study/NCT07316361 | https://clinicaltrials.gov/study/NCT03568097 | https://clinicaltrials.gov/study/NCT05608395 | https://clinicaltrials.gov/study/NCT03267940 | https://clinicaltrials.gov/study/NCT02882308 | https://clinicaltrials.gov/study/NCT06334991 | https://clinicaltrials.gov/study/NCT04459078 | https://clinicaltrials.gov/study/NCT06532539 | https://clinicaltrials.gov/study/NCT06279130 | https://clinicaltrials.gov/study/NCT04116541